2 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart FailureAcute Decompensated Heart Failure (ADHF)RecruitingPhase 32026-08-26NCT07038356
Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) PlacementChemically-Induced Disorders, Digestive System Diseases, Fibrosis, Heart Decompensation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cardiovascular disorder, cirrhosis of liver, heart disorder, heart failure, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorderRecruitingNot applicable2026-08-04NCT06814990